The HIV Prevention Trials Network has begun the process of screening men for possible involvement in what may be a landmark study.
The study, known as HPTN 073, will be studying pre-exposure prophylaxis initiation and adherence in HIV-negative black men who have sex with men. The study will occur at three of the network’s United States research facilities in Washington, D.C.; Chapel Hill, North Carolina; and Los Angeles. Those involved in the study will participate through colleges near the research facilities: George Washington University, University of North Carolina, and University of California, Los Angeles.
For more information tune into a live Twitter chat will be hosted on Wednesday, August 14 at 1p.m. EST on the HIV Prevention Trials Network’s page, @HIVptn, featuring the hashtag #PrEPChat.